Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Albireo Pharma, Inc. is a biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 13.7% downward over the last 30 days.
BEST Inc. (BEST - Free Report) is a smart supply chain service provider in China. The Zacks Consensus Estimate for its current year earnings has been revised 51.9% downward over the last 30 days.
Cortexyme, Inc. is focussed on developing therapeutics for Alzheimer's disease and other degenerative disorders. The Zacks Consensus Estimate for its current year earnings has been revised 6.3% downward over the last 30 days.
Energy Fuels Inc. (UUUU - Free Report) is engaged in the extraction, recovery, exploration, and sale of conventional and in situ uranium recovery in the United States. The Zacks Consensus Estimate for its current year earnings has been revised 23.5% downward over the last 30 days.
Kaleyra, Inc. is a provider of a cloud communications platform for enterprises. The Zacks Consensus Estimate for its current year earnings has been revised 7% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Albireo Pharma, Inc. is a biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 13.7% downward over the last 30 days.
BEST Inc. (BEST - Free Report) is a smart supply chain service provider in China. The Zacks Consensus Estimate for its current year earnings has been revised 51.9% downward over the last 30 days.
Cortexyme, Inc. is focussed on developing therapeutics for Alzheimer's disease and other degenerative disorders. The Zacks Consensus Estimate for its current year earnings has been revised 6.3% downward over the last 30 days.
Energy Fuels Inc. (UUUU - Free Report) is engaged in the extraction, recovery, exploration, and sale of conventional and in situ uranium recovery in the United States. The Zacks Consensus Estimate for its current year earnings has been revised 23.5% downward over the last 30 days.
Kaleyra, Inc. is a provider of a cloud communications platform for enterprises. The Zacks Consensus Estimate for its current year earnings has been revised 7% downward over the last 30 days.
View the entire Zacks Rank #5 List.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on UUUU - FREE
Get the latest research report on BEST - FREE